A product designed to screen for acute coronary syndrome and PE
“BreathQuant Medical Systems, Inc. is pleased to announce the worldwide launch of its revolutionary PREtest Consult product. The product utilizes a large database of patients with known outcomes to determine the likelihood that a patient presenting to an emergency department or clinic has a life threatening disease.
The risk score generated by this test aids physicians in their decision to pursue further testing and hospitalization.
If the physician discharges the patient without further workup, the physician has mitigated malpractice risk by documenting his/her quantitative basis for decision making. At the same time, this quantitative basis also helps in reducing unnecessary testing, which is a known contributor to the overcrowding epidemic that affects hospitals across the country.”
Certainly defensive admissions have been recently discussed as a problem. Will the results from quantitative software such as these stand up in court?